Nursing care
Famotidine: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Famotidine is an H2 receptor antagonist that reduces gastric acid production faster than a proton pump inhibitor, but with a weaker overall effect. The exam-relevant point is renal clearance: dose must be reduced in renal impairment, and failure to adjust it risks accumulation and CNS effects, particularly in older adults.
Mechanism, simply
Famotidine blocks histamine-2 receptors on gastric parietal cells. Less histamine signalling means less stimulation of the proton pumps that secrete hydrogen ions, so acid output falls. It does not touch the pump directly, which is why its ceiling effect on acid suppression sits below that of omeprazole or pantoprazole.
The onset is quick, often within an hour, and that speed is the tradeoff for potency. A PPI takes days to reach full effect but suppresses acid more completely. Famotidine is the faster, shallower option, useful when rapid symptom control matters more than maximal suppression.
Indications you will see on the ward
Expect famotidine for GERD, peptic ulcer disease, and stress ulcer prophylaxis in patients who are NPO, ventilated, or on high-dose corticosteroids. It is also common as a pre-procedure order to reduce aspiration risk from gastric acid, and in combination antihistamine protocols for anaphylaxis alongside an H1 blocker.
IV famotidine appears frequently in ICU and post-op orders for stress ulcer prevention. Oral formulations show up in general medical-surgical patients managing reflux or maintenance therapy after an ulcer has healed. Recognising which indication is in play tells you what response to expect and how urgently the dose matters.
Assessment before administration
Check renal function before every dose review. Creatinine clearance below 50 mL/min requires a reduced dose or extended interval; this is the single fact most likely to appear on an exam item about famotidine. Skipping this check in an older adult with unrecognised renal decline is the classic error.
Ask about current GI symptoms, black or tarry stools, and any NSAID or anticoagulant use that could compound bleeding risk. Confirm the route ordered matches the clinical picture, IV for someone who is NPO or critically ill, oral for someone tolerating intake, and verify no allergy to H2 blockers is documented.
Toxicity and the antidote
Famotidine has a wide safety margin and no specific antidote exists because clinically significant toxicity from oral or standard IV dosing is rare. The real risk lies in accumulation from unadjusted renal dosing rather than acute overdose.
In renal impairment, accumulated famotidine can cause confusion, agitation, or somnolence, especially in older adults, and this presentation is often mistaken for delirium from another cause. Management is supportive: hold the dose, reassess renal function, and monitor mental status until levels clear. There is no reversal agent to give.
Interactions that matter
Famotidine raises gastric pH, which can reduce absorption of drugs that need an acidic environment, including some azole antifungals like ketoconazole and certain iron formulations. Space administration when a prescriber wants both drugs to work as intended.
Unlike cimetidine, famotidine does not significantly inhibit hepatic cytochrome P450 enzymes, so it carries far fewer drug-drug interactions overall. That distinction is worth knowing when a question contrasts the two H2 blockers directly.
What the patient must be told
Tell the patient to take it as prescribed, with or without food depending on the product, and not to double up if a dose is missed. Explain that relief may come faster than with other reflux medicines, but that persistent or worsening symptoms, black stools, or vomiting blood need prompt reporting.
Warn older patients or anyone with kidney disease that confusion or unusual drowsiness should be reported, since it may signal drug accumulation rather than something unrelated. Advise against long-term self-treatment without follow-up, since ongoing reflux warrants further evaluation rather than indefinite self-medication.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Is famotidine safe in kidney disease?
It can be used, but the dose or interval must be reduced when creatinine clearance falls below 50 mL/min. Without that adjustment, the drug accumulates and can cause confusion or excessive sedation, particularly in older adults.
Why does famotidine work faster than a PPI?
It blocks histamine receptors directly, producing effect within about an hour, while a PPI needs to bind and inhibit the proton pump itself, a process that takes days to reach full suppression. The tradeoff is that famotidine's ceiling effect is lower.
Can famotidine be given with an antacid?
Yes, but timing matters less for famotidine than for a PPI since it does not require an acidic stomach to be absorbed. Still, separate administration if the patient is also taking a drug that needs gastric acid for its own absorption.
What is the antidote for famotidine overdose?
There is no specific antidote. Toxicity is uncommon at standard doses, and management centres on supportive care and monitoring, with particular attention to renal function and mental status.
More on pharmacology
Guides on this